<DOC>
	<DOCNO>NCT02321111</DOCNO>
	<brief_summary>The purpose study determine whether pharmacologic inhibition Toll-like receptor 4 ( TLR4 ) eritoran injection ( E5564 ) prevent lipid-induced insulin resistance lean , normal glucose tolerant ( NGT ) subject .</brief_summary>
	<brief_title>The Role TLR4 Lipid-induced Insulin Resistance</brief_title>
	<detailed_description>E5564 = Eritoran</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Subjects capable give informed consent . lean ( BMI &lt; 26 kg/m2 ) normal glucosetolerant subject ( completers ) without family history Type 2 diabetes mellitus ( DM ) Both gender . ( 50 % male ) Age = 1865 year . Older subject exclude age proinflammatory state . All ethnic group Premenopausal woman follicular phase , nonlactating , negative pregnancy test . Postmenopausal woman stable dose expose hormone replacement &gt; =6 month . Lab : Hematocrit &gt; =34 % , serum creatinine &lt; =1.4 mg/dL , normal electrolyte , urinalysis , coagulation test . Liver function test 2x normal range . Stable body weight ( +/1 % ) &gt; =3 month . One less session strenuous exercise/wk last 6 month . Presence diabetes impaired glucose tolerance base ADA criterion ; Current treatment drug know affect glucose lipid homeostasis . Subjects stable dose statin ( &gt; 3months ) eligible . Nonsteroidal antiinflammatory drug systemic steroid use 1 week within 3 month . Current treatment anticoagulant ( warfarin ) . Aspirin ( 325 mg ) clopidogrel permit hold seven day prior biopsy . History heart disease ( New York Heart Classification great class II ; nonspecific STT wave change ECG ) , peripheral vascular disease , pulmonary disease , smoker . Poorly control blood pressure ( systolic BP &gt; 160 , diastolic BP &gt; 90 mmHg ) . Active inflammatory , autoimmune , infectious , hepatic , gastrointestinal , malignant , psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Insulin signal glucose disposal muscle</keyword>
	<keyword>Hepatic insulin sensitivity</keyword>
	<keyword>TLR4 signal inflammatory gene expression</keyword>
	<keyword>Plasma cytokine concentration</keyword>
	<keyword>Intramyocellular diacylglycerol ceramide content</keyword>
</DOC>